TIGIT: A Breakthrough Target to Combat Tumor Immunotherapy Resistance
Malignant tumors continue to pose one of the most formidable challenges in modern medicine, persistently eluding the full efficacy of ...
Malignant tumors continue to pose one of the most formidable challenges in modern medicine, persistently eluding the full efficacy of ...
In the rapidly evolving field of cancer immunotherapy, adoptive cell therapy (ACT) and immune cell engagers (ICEs) are carving out ...
In a groundbreaking new study published in the British Journal of Cancer, scientists have unveiled a novel mechanism by which ...
In the realm of oncology, the challenges posed by immunologically unresponsive tumors have remained a significant hurdle, particularly in the ...
In a groundbreaking study poised to redefine therapeutic strategies for head and neck squamous cell carcinoma (HNSCC), researchers have uncovered ...
In a groundbreaking study published recently in Cell Death Discovery, a team of researchers led by Miao, N., Kang, Z., ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine